UPDATE 1-Vivus, Auxilium sign $300 mln deal for erectile dysfunction drug
October 11, 2013 at 08:02 AM EDT
Oct 11 (Reuters) - Vivus Inc's erectile dysfunction drug will be marketed by Auxilium Pharmaceuticals Inc in the United States and Canada in a deal worth up to $300 million, including an upfront licensing fee of $30 million.